Research and Markets: Lucentis (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/km8pdn/lucentis) has announced the addition of the "Lucentis (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022" report to their offering.
“Lucentis (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022”
The entire market for microvascular complications of diabetes (MCD) - diabetic nephropathy, retinopathy, and neuropathy - is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid uptake of novel anti-VEGF therapies and is experiencing a strong growth. On the other hand, the diabetic neuropathy and nephropathy segments face the barrier in and increasing number of generic competitors.
Lucentis (ranibizumab) is a humanized fragment antigen-binding(Fab) fragment of an immunoglobulin G1 (IgG1) monoclonal antibody (mAb) that specifically binds to all isoforms of vascular endothelial growth factor (VEGF)-A, thereby preventing the binding of VEGF-A to its vascular endothelial growth factor receptor (VEGFR)-1 and (VEGFR-2) (Bandello et al., 2012).
- Overview of MCD, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on Lucentis including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for Lucentis for the top seven countries from 2012 to 2022.
- Sales information covered for the US, France, Germany, Italy, Spain, the UK and Japan.
Key Topics Covered:
List of Tables
List of Figures
For more information visit http://www.researchandmarkets.com/research/km8pdn/lucentis
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.